Friday, August 26, 2005

FDA Delays Morning-After Pill Decision

Yet Again.

First they delayed it to give time to seek more detailed information on use of the pills by 16- and 17-year-olds.

Then they delayed it because it might encourage risky sexual behavior.

Now the FDA is delaying the morning-after pill, or plan-b, because... well, they seem to have run out of reasons why. But they assure us it isn't politics or in any way related to a conservative agenda.


Friday, FDA essentially boiled the issue down to regulatory precedent: Selling the same dose of a drug by prescription and without at the same time and for the same medical use has never been done. The FDA will allow 60 days of public comment on how to take such a step and enforce an age limit, but Crawford would not say how soon the agency could evaluate those comments and rule.


"It seems improbable to me that ... politics hasn't trumped science here, which is a tragedy," said Dr. Alastair Wood of Vanderbilt University, who chaired the FDA advisory committee that evaluated Plan B.

"They are acting in bad faith," said Kirsten Moore of the Reproductive Health Technologies Project, noting that FDA already has logged 17,400 letters from the public and advocacy groups urging it to take one side or the other on Plan B. "How many more comments do they need?"

The article is here. And notice it's in the Friday news dump?


Post a Comment

<< Home

free web page hit counter